These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 8027926)
41. Dosage of nifedipine in hypertensive crises of infants and children. Lopez-Herce J; Dorao P; de la Oliva P; Delgado MA; Martinez MC; Ruza F Eur J Pediatr; 1989 Nov; 149(2):136-7. PubMed ID: 2591406 [TBL] [Abstract][Full Text] [Related]
42. Development and characterization of buccoadhesive nifedipine tablets. Varshosaz J; Dehghan Z Eur J Pharm Biopharm; 2002 Sep; 54(2):135-41. PubMed ID: 12191683 [TBL] [Abstract][Full Text] [Related]
43. [Nitroglycerin in comparison with nifedipine in patients with hypertensive crisis]. Bussmann WD; Kenedi P; von Mengden HJ; Nast HP; Rachor M Z Kardiol; 1993 Jan; 82(1):33-7. PubMed ID: 8470417 [TBL] [Abstract][Full Text] [Related]
44. Efficacy and safety of nifedipine tablets for the acute treatment of severe hypertension in pregnancy. Brown MA; Buddle ML; Farrell T; Davis GK Am J Obstet Gynecol; 2002 Oct; 187(4):1046-50. PubMed ID: 12389003 [TBL] [Abstract][Full Text] [Related]
45. Studies on improvement of pharmaceutical preparations prescribed in hospitals. V. Nifedipine hollow type suppository. Namiki N; Yokoyama H; Moriya K; Fukuda M; Takashima T; Tamura H; Yuasa H; Kanaya Y Drug Des Deliv; 1986 Nov; 1(2):167-73. PubMed ID: 3509330 [TBL] [Abstract][Full Text] [Related]
46. Pharmacokinetics and pharmacodynamics of conventional and slow release forms of nifedipine in essential hypertensive patients. Imai Y; Abe K; Sasaki S; Nihei M; Sekino H; Yoshinaga K Tohoku J Exp Med; 1986 Apr; 148(4):421-38. PubMed ID: 3738908 [TBL] [Abstract][Full Text] [Related]
47. The influence of nimodipine on hemodynamic parameters and peak and trough plasma concentrations of nifedipine chronically administered to elderly hypertensive patients. Breuel HP; Mück W; Heine PR; Schmage N; Niklaus H; Kuhlmann J Int J Clin Pharmacol Ther; 1995 Feb; 33(2):109-13. PubMed ID: 7757309 [TBL] [Abstract][Full Text] [Related]
48. [Pharmacodynamics of cordipine in hypertension]. Demidenko IV; Ivleva AIa; Polotskaia EL; Moiseev VS Sov Med; 1988; (4):81-5. PubMed ID: 3043715 [No Abstract] [Full Text] [Related]
49. Is sublingual nifedipine administration superior to oral administration in the active treatment of hypertension? Diker E; Ertürk S; Akgün G Angiology; 1992 Jun; 43(6):477-81. PubMed ID: 1595942 [TBL] [Abstract][Full Text] [Related]
50. [Evaluation of the antihypertensive effect of capsule and tablet forms of nifedipine in moderate hypertension]. Thibonnier M; Sassano P; Corvol P Arch Mal Coeur Vaiss; 1985 Nov; 78 Spec No():25-8. PubMed ID: 3937501 [TBL] [Abstract][Full Text] [Related]
51. Bioavailability and pharmacokinetics of nifedipine administered by different routes in healthy volunteers. Palma-Aguirre JA; Rosas-Alcázar G; Rodríguez JM; León-Urrea F; Montoya-Cabrera MA Arch Invest Med (Mex); 1989; 20(2):129-35. PubMed ID: 2604495 [TBL] [Abstract][Full Text] [Related]
52. Forearm vascular responses in normotensives and hypertensives after sublingual nifedipine. Houston DS; Fernandez PG; Snedden W Clin Invest Med; 1985; 8(1):56-61. PubMed ID: 3987119 [TBL] [Abstract][Full Text] [Related]
53. Effect of slow release nifedipine tablets in patients with essential hypertension. Imai Y; Abe K; Munakata M; Sasaki S; Minami N; Sakuma H; Hashimoto J; Watanabe N; Sakuma M; Sekino H Arzneimittelforschung; 1992 Dec; 42(12):1434-8. PubMed ID: 1288507 [TBL] [Abstract][Full Text] [Related]
55. Evaluation of the effect of the sublingually administered nifedipine and captopril via transcranial doppler ultrasonography during hypertensive crisis. Gemici K; Baran I; Bakar M; Demircan C; Ozdemir B; Cordan J Blood Press; 2003; 12(1):46-8. PubMed ID: 12699135 [TBL] [Abstract][Full Text] [Related]